Graciela Andreï

16.5k total citations
509 papers, 13.0k citations indexed

About

Graciela Andreï is a scholar working on Epidemiology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Graciela Andreï has authored 509 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 277 papers in Epidemiology, 166 papers in Organic Chemistry and 164 papers in Infectious Diseases. Recurrent topics in Graciela Andreï's work include Herpesvirus Infections and Treatments (155 papers), Cytomegalovirus and herpesvirus research (154 papers) and HIV/AIDS drug development and treatment (135 papers). Graciela Andreï is often cited by papers focused on Herpesvirus Infections and Treatments (155 papers), Cytomegalovirus and herpesvirus research (154 papers) and HIV/AIDS drug development and treatment (135 papers). Graciela Andreï collaborates with scholars based in Belgium, United States and United Kingdom. Graciela Andreï's co-authors include Robert Snoeck, Erik De Clercq, Jan Balzarini, Johan Neyts, Dominique Schols, Lieve Naesens, Antonı́n Holý, Christopher McGuigan, Jan Balzarini and Sophie Duraffour and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Graciela Andreï

501 papers receiving 12.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Graciela Andreï 4.7k 4.6k 4.1k 3.0k 1.6k 509 13.0k
Robert Snoeck 6.5k 1.4× 5.5k 1.2× 5.0k 1.2× 4.8k 1.6× 2.3k 1.4× 556 17.3k
Antonı́n Holý 4.6k 1.0× 3.6k 0.8× 5.9k 1.4× 5.3k 1.8× 1.3k 0.8× 587 12.5k
Lieve Naesens 4.4k 0.9× 2.2k 0.5× 3.2k 0.8× 3.5k 1.2× 1.4k 0.9× 284 9.6k
Jan Balzarini 1.7k 0.4× 5.7k 1.2× 4.4k 1.1× 2.7k 0.9× 1.4k 0.8× 515 11.7k
Masanori Baba 3.3k 0.7× 3.6k 0.8× 5.0k 1.2× 6.9k 2.3× 1.2k 0.7× 372 16.0k
Earl R. Kern 6.0k 1.3× 1.2k 0.3× 1.9k 0.5× 1.5k 0.5× 1.2k 0.7× 220 9.2k
Timothy M. Block 6.3k 1.4× 1.1k 0.2× 4.4k 1.1× 1.9k 0.6× 959 0.6× 232 12.6k
Jan Balzarini 1.4k 0.3× 2.7k 0.6× 3.8k 0.9× 2.2k 0.7× 689 0.4× 213 7.6k
Johan Neyts 6.5k 1.4× 3.7k 0.8× 6.6k 1.6× 10.1k 3.3× 1.6k 1.0× 688 24.7k
Giovanni Maga 878 0.2× 2.4k 0.5× 5.5k 1.3× 2.2k 0.7× 937 0.6× 270 9.9k

Countries citing papers authored by Graciela Andreï

Since Specialization
Citations

This map shows the geographic impact of Graciela Andreï's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graciela Andreï with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graciela Andreï more than expected).

Fields of papers citing papers by Graciela Andreï

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graciela Andreï. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graciela Andreï. The network helps show where Graciela Andreï may publish in the future.

Co-authorship network of co-authors of Graciela Andreï

This figure shows the co-authorship network connecting the top 25 collaborators of Graciela Andreï. A scholar is included among the top collaborators of Graciela Andreï based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graciela Andreï. Graciela Andreï is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tilloy, Valentin, Sunwen Chou, William D . Rawlinson, et al.. (2024). Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD). Antiviral Research. 231. 106016–106016. 3 indexed citations
3.
Wang, Mengmeng, Lingyun Li, Piet Herdewijn, et al.. (2023). Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N4-hydroxycytidine (NHC) and a 3′-fluoro-substituted analogue of NHC. Bioorganic Chemistry. 135. 106527–106527. 5 indexed citations
4.
Snoeck, Robert, Vera A. Alferova, Andrey Kulbachinskiy, et al.. (2023). Phenotypic Test of Benzo[4,5]imidazo[1,2-c]pyrimidinone-Based Nucleoside and Non-Nucleoside Derivatives against DNA and RNA Viruses, Including Coronaviruses. International Journal of Molecular Sciences. 24(19). 14540–14540. 1 indexed citations
5.
6.
Kozlovskaya, Liubov I., Анна А. Штро, Alexey A. Chistov, et al.. (2021). Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses. European Journal of Medicinal Chemistry. 220. 113467–113467. 15 indexed citations
7.
Harej, Anja, Višnja Stepanić, Krešimir Pavelić, et al.. (2019). Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives. European Journal of Medicinal Chemistry. 184. 111739–111739. 32 indexed citations
8.
Aguilera, Renato J., Graciela Andreï, Robert Snoeck, et al.. (2019). Synthesis and Evaluations of “1,4‐Triazolyl Combretacoumarins” and Desmethoxy Analogs. European Journal of Organic Chemistry. 2019(33). 5610–5623. 7 indexed citations
9.
Baszczyňski, Ondřej, Martin Kaiser, Michal Česnek, et al.. (2018). Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus. Antiviral chemistry & chemotherapy. 26. 2663932538–2663932538. 4 indexed citations
10.
Bray, Mike, Graciela Andreï, Ester Ballana, et al.. (2018). Meeting report: 31st International Conference on Antiviral Research. Antiviral Research. 158. 88–102. 8 indexed citations
11.
Wouters, Jens, Pieter Vermeersch, Katarzyna Bloch, et al.. (2018). Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma. Journal of Translational Medicine. 16(1). 1–1. 323 indexed citations
12.
Andreï, Graciela, Kara Carter, Zlatko Janeba, et al.. (2017). Highlights of the 30th International Conference on Antiviral Research. Antiviral Research. 145. 184–196. 10 indexed citations
13.
14.
Brisse, Ellen, et al.. (2014). Acute primary infection with mouse cytomegalovirus represents a natural animal model for virus-associated secondary hemophagocytic lymphohistiocytosis. Lirias (KU Leuven). 1 indexed citations
15.
Duraffour, Sophie, Graciela Andreï, & Robert Snoeck. (2010). Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.. PubMed. 13(3). 181–91. 29 indexed citations
16.
Andreï, Graciela, Don B. Gammon, Pierre Fiten, et al.. (2006). Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein Mice. Journal of Virology. 80(19). 9391–9401. 70 indexed citations
17.
Carangio, Antonella, Christopher McGuigan, Graciela Andreï, et al.. (2002). Anti-varicella-zoster virus bicyclic nucleosides: Synthesis and in vitro evaluation of 2 ',3 '-dideoxy nucleoside derivatives. Antiviral Research. 1 indexed citations
18.
Tronchet, Jean M. J., Imre Kovács, Pierre J. Dilda, et al.. (2001). SYNTHESIS AND ANTI-HIV ACTIVITY OF THYMIDINE ANALOGUES BEARING A 4′-CYANOVINYL GROUP AND SOME DERIVATIVES THEREOF. Nucleosides Nucleotides & Nucleic Acids. 20(12). 1927–1939. 6 indexed citations
19.
Andreï, Graciela, et al.. (1990). Meliacine, an Antiviral Compound from Melia azedarach L., Inhibits Interferon Production. Journal of Interferon Research. 10(5). 469–475. 21 indexed citations
20.
Andreï, Graciela, et al.. (1985). Ensayos de citotoxicidad y actividad antiviral de extractos crudos y semipurificados de hojas verdes de Melia azedarach L. Revista Argentina de Microbiología. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Snoeck Breakdown of academic impact, for papers by Antonı́n Holý Breakdown of academic impact, for papers by Lieve Naesens Breakdown of academic impact, for papers by Jan Balzarini Breakdown of academic impact, for papers by Masanori Baba Breakdown of academic impact, for papers by Earl R. Kern Breakdown of academic impact, for papers by Timothy M. Block Breakdown of academic impact, for papers by Jan Balzarini Breakdown of academic impact, for papers by Johan Neyts Breakdown of academic impact, for papers by Giovanni Maga
Rankless by CCL
2026